On Monday, Bausch Health Companies Inc (NYSE: BHC) opened higher 10.76% from the last sessionbefore settling in for the closing price of $6.32. Price fluctuations for BHC have ranged from $3.96 to $11.46 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 1.03%. Company’s average yearly earnings per share was noted 4.10% at the time writing. With a float of $320.79 million, this company’s outstanding shares have now reached $365.24 million.
The extent of productivity of a business whose workforce counts for 20270 workers is very important to gauge. In terms of profitability, gross margin is 92.3%, operating margin of 11.91%, and the pretax margin is -3.85%.
Bausch Health Companies Inc (BHC) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Bausch Health Companies Inc is 12.61%, while institutional ownership is 78.17%. The most recent insider transaction that took place on Sep 06 ’24, was worth 83,028. In this transaction EVP, General Counsel of this company sold 13,370 shares at a rate of $6.21, taking the stock ownership to the 435,198 shares. Before that another transaction happened on Sep 06 ’24, when Company’s Officer proposed sale 13,370 for $6.21, making the entire transaction worth $83,028.
Bausch Health Companies Inc (BHC) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 4.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.60% during the next five years compared to 32.76% growth over the previous five years of trading.
Bausch Health Companies Inc (NYSE: BHC) Trading Performance Indicators
Check out the current performance indicators for Bausch Health Companies Inc (BHC). In the past quarter, the stock posted a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.28. Likewise, its price to free cash flow for the trailing twelve months is 2.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.29, a number that is poised to hit 1.04 in the next quarter and is forecasted to reach 4.16 in one year’s time.
Technical Analysis of Bausch Health Companies Inc (BHC)
The latest stats from [Bausch Health Companies Inc, BHC] show that its last 5-days average volume of 2.72 million was inferior to 3.11 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 83.25%. Additionally, its Average True Range was 0.28.
During the past 100 days, Bausch Health Companies Inc’s (BHC) raw stochastic average was set at 60.26%, which indicates a significant decrease from 96.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.50% in the past 14 days, which was lower than the 58.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.26, while its 200-day Moving Average is $7.57. Now, the first resistance to watch is $7.17. This is followed by the second major resistance level at $7.34. The third major resistance level sits at $7.63. If the price goes on to break the first support level at $6.71, it is likely to go to the next support level at $6.42. The third support level lies at $6.25 if the price breaches the second support level.
Bausch Health Companies Inc (NYSE: BHC) Key Stats
There are currently 360,990K shares outstanding in the company with a market cap of 2.57 billion. Presently, the company’s annual sales total 8,757 M according to its annual income of -592,000 K. Last quarter, the company’s sales amounted to 2,403 M and its income totaled 10,000 K.
